Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024 J.M. Remes-Troche; E. Coss-Adame; M. Schmulson; K.R. García-Zermeño; M. Amieva-Balmori; R. Carmona-Sánchez; O. Gómez-Escudero; P.C. Gómez-Castaños; M.E. Icaza-Chávez; A. López-Colombo; E.C. Morel-Cerda; M.Á. Valdovinos-Díaz; L.R. Valdovinos-García; A.S. Villar-Chávez;

Prevalence of primary eosinophilic colitis in patients with chronic diarrhea and diarrhea-predominant irritable bowel syndrome R. Carmona-Sánchez; M.A. Carrera-Álvarez; C. Peña-Zepeda;

Organic colonic lesions in patients with irritable bowel syndrome: A comparative study F. Ejtehadi; M.H. Anbardar; M.H. Imanieh; R. Niknam; G.R. Sivandzadeh;